MasterCard announced on Monday it would provide a $500,000 grant to Weill Cornell Medical College to establish a researcher-in-residence position to support efforts to eliminate cancer for women.
“We are humbled by MasterCard’s extraordinary generosity in support of our efforts to make treatment of female cancers more precise and effective,” Weill Cornell Cancer Center Director Lewis C. Cantley said. “This grant ensures that Weill Cornell can continue the critical scientific investigation that leads to breakthrough therapies.”
Cantley heads Stand Up to Cancer’s Dream Team, which targets PI3 kinases—enzymes linked to a number of important cellular functions—in women’s cancers. The team focuses on developing procedures and clinical trials to provide personalized care to address a number of cancers, including breast, ovarian and uterine cancers.
“We support communities, programs and causes that impact our employees, cardholders and customers,” MasterCard President and CEO Ajay Banga said. “Through our relationship with Weill Cornell, we hope to spark the research that will deliver treatments that will turn cancer patients into cancer survivors, providing them bright futures.”
Earlier this year, Weill Cornell opened the MasterCard Principal Investigator Office Suite in honor of the company’s contributions towards cancer research. The office will help maximize collaboration between teams dedicated to cancer research.
Over the past four years, MasterCard has helped raise over $17 million for SU2C efforts to fund research.